Skip to main navigation Skip to search Skip to main content

Acalabrutinib for treatment of diffuse large B-cell lymphoma: Results from a phase Ib study

  • Paolo Strati
  • , Sven de Vos
  • , Jia Ruan
  • , Kami J. Maddocks
  • , Christopher R. Flowers
  • , Simon Rule
  • , Priti Patel
  • , Yan Xu
  • , Helen Wei
  • , Melanie M. Frigault
  • , Roser Calvo
  • , Martin J.S. Dyer*
  • *Corresponding author for this work
  • University of Texas Health Science Center at Houston
  • University of California at Los Angeles
  • Cornell University
  • Ohio State University
  • Emory University
  • AstraZeneca
  • University of Leicester

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2775-2778
Number of pages4
JournalHaematologica
Volume106
Issue number10
DOIs
Publication statusPublished - Oct 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Hematology

Cite this